Eric Bednarski - Profile and Investment Details

Investor Profile

Eric Bednarski is a Venture Capital, Private Equity Firm. based in Boston, Massachusetts, United States. with a diverse investment portfolio that includes companies such as Vantia Therapeutics, Spherics, Onbone, Zipline Medical, Solx, Oxxon Therapeutics, Horizon Discovery, Clavis Pharma, Tarsa Therapeutics, GT Medical Technologies, Cara Therapeutics, SkyCell, Heptares Therapeutics, Providence Medical Technology, Vertos Medical, Serentis, Cheetah Medical, Biotheranostics, BioVex, De Novo Pharmaceuticals, Patient Connect, BioXell, Wilson Therapeutics, eXmoor Pharma, PregLem, Aegerion Pharmaceuticals, AmbioPharm, Lombard Medical plc, Momenta Pharmaceuticals, Evotec Neurosciences, VitalConnect, Avantium Technologies, Xention, Paragon 28, eZono, Beacon Endoscopic, Vascular Pathways, MDxHealth, AccuVein.. Over time, Eric Bednarski has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Eric Bednarski is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Wearables, Women Founded, Medical Testing, HR Tech, Android, Life Science, Analytics, Medical Device, Healthcare, Biotechnology, Supply Chain Management, Hardware, Logistics, Health Diagnostics, Medical, Media and Entertainment, Developer Platform, Pharmaceuticals. may find it worthwhile to explore potential connections with Eric Bednarski, as their portfolio suggests a familiarity and interest in this area.

Understanding Eric Bednarski’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.